CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is
providing this corporate update.


Calyx is the largest shareholder of Agrisoma Biosciences Inc. ("Agrisoma"), with
49.98% of the issued and outstanding shares. BDC Capital Inc. ("BDC"), which
owns 49.96% of Agrisoma, advanced to Agrisoma $1 million by way of a promissory
note in November, 2012 and a further $1 million in November, 2013 (the "BDC
Notes"). The BDC Notes are the only secured debt of Agrisoma and have a maturity
date of March 31st, 2014. Calyx has no secured debt with BDC or Agrisoma.


Calyx has met with BDC and Agrisoma to identify and consider financing solutions
that would work for all parties. After discussions with Agrisoma and BDC with
Calyx management, Calyx appointed an Independent Committee of the Board of
Directors, a Financial Advisor and a Legal Advisor to consider any and all
strategic options that would be in the best interests of Calyx shareholders.


Following several meetings, the Independent Committee recommended to the Calyx
Board that it make an Offer to Finance to Agrisoma and the recommendation was
accepted unanimously by the Calyx Board. An Offer to Finance was presented to
Agrisoma on Saturday, March 22nd, 2014.


It is Calyx's position, the Offer to Finance meets the short term requirements
of Agrisoma and preserves the interests of all Agrisoma stakeholders.


The Independent Committee of the Board and Calyx's Financial Advisor are
exploring every avenue to maximize value for Calyx shareholders.


About Calyx 

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Calyx is the largest
shareholder of Agrisoma Biosciences Inc., a company which is producing a new
proprietary non-food energy feedstock crop - carinata - which yields oil that
can be refined into fuels that work in existing engines as a 100 percent
petroleum substitute. From seed to sky, fuels produced from carinata
substantially reduce carbon and other harmful emissions, and help to reduce
global petroleum dependence. Carinata was used to fly the world's first 100%
biojet flight, as achievement that Popular Science called one of the top science
events on the planet in 2012. For further information about Calyx, please visit
www.calyxbio.com. For more information on Agrisoma, please visit
www.agrisoma.com. 


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
Don Konantz
President & CEO
604-649-5961
dkonantz@calyxbio.com


Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2024 to May 2024

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2023 to May 2024